Immunovant Stock Price on September 27, 2021 Breakdown

IMVT -  USA Stock  

USD 7.55  0.22  2.83%

Immunovant Stock price history is provided at the adjusted basis, taking into account all of the recent filings. As of today, the current price of Immunovant is  7.55 , as last reported on the 30th of November, with the highest price reaching  8.03  and the lowest price hitting  7.51  during the day.
Immunovant holds Efficiency (Sharpe) Ratio of -0.089, which attests that the entity had -0.089% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Immunovant exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Immunovant risk adjusted performance of (0.023303), and Market Risk Adjusted Performance of (0.10) to validate the risk estimate we provide.

Immunovant Stock Price History 

 
Refresh
Net Income Common Stock is likely to drop to about (115.9 M) in 2021. Price to Book Value is likely to gain to 4.92 in 2021, whereas Price to Earnings Ratio are likely to drop (14.19)  in 2021.

Immunovant Main Headline on 27th of September 2021

Financial Statements
by SEC
Financial Statements and Exhibits. Regulation FD Disclosure

Immunovant Valuation on September 27, 2021

It is possible to determine the worth of Immunovant on a given historical date. On September 27, 2021 Immunovant was worth 8.69 at the beginning of the trading date compared to the closed value of 8.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunovant stock. Still, in general, we apply an absolute valuation method to find Immunovant's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunovant's related companies.
 Open High Low Close Volume
  8.78    8.84    8.61    8.65    347,000  
09/27/2021
  8.69    9.00    8.40    8.97    724,200  
  8.92    9.23    8.80    9.03    538,400  
Backtest Immunovant  |  Immunovant History  |  Immunovant Valuation   PreviousNext  
Open Value
8.69
27th of September 2021
8.97
Closing Value
16.12
Upside

Immunovant Trading Date Momentum on September 27, 2021

On September 28 2021 Immunovant was traded for  9.03  at the closing time. The top price for the day was 9.23  and the lowest listed price was  8.80 . The trading volume for the day was 538.4 K. The trading history from September 28, 2021 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 0.67% . The trading delta at closing time against the current closing price is 0.45% .

Immunovant Fundamentals Correlations and Trends

By evaluating Immunovant's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunovant's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunovant financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Immunovant Stock history

Immunovant investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunovant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunovant will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunovant historical stock prices may prove useful in developing a viable investing in Immunovant
Last ReportedProjected for 2021
Weighted Average Shares87.8 M75.7 M
Weighted Average Shares Diluted87.8 M75.7 M
Issuance Purchase of Equity Shares387.5 M418.1 M
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. Immunovant operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 68 people.

Immunovant Quarterly Market Capitalization

999.34 MillionShare

Immunovant Stock Technical Analysis

Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunovant technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunovant trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Immunovant Period Price Range

Low
September 27, 2021
High

 8.69 

  

 8.97 

0.283.22%

Immunovant November 30, 2021 Market Strength

Market strength indicators help investors to evaluate how Immunovant stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunovant shares will generate the highest return on investment. By undertsting and applying Immunovant stock market strength indicators, traders can identify Immunovant entry and exit signals to maximize returns

Immunovant Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immunovant stock's direction in advance. Along with the technical and fundamental analysis of Immunovant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunovant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please see Risk vs Return Analysis. Note that the Immunovant information on this page should be used as a complementary analysis to other Immunovant's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Immunovant Stock analysis

When running Immunovant price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Is Immunovant's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunovant. If investors know Immunovant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunovant listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunovant is measured differently than its book value, which is the value of Immunovant that is recorded on the company's balance sheet. Investors also form their own opinion of Immunovant's value that differs from its market value or its book value, called intrinsic value, which is Immunovant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunovant's market value can be influenced by many factors that don't directly affect Immunovant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunovant's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunovant value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunovant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.